NextGen-O2k Exploitation
From Bioblast
Revision as of 15:54, 16 June 2020 by Tindle Lisa (talk | contribs)
Template:MitoFit highlights page name
The revolutionary all-in-one instrument to conquer mitochondrial disease.
WP4: Exploitation
Abstract
- Preparation for a successful market launch of the NextGen-O2k.
Progress and next steps
- 2020-05-22: Successful registration of “NextGen-O2k”, “DatLab” and “High-Resolution Respirometry” as EU-trademarks
- 2020-05-08/15: Our Customer Relations Elf, Carolina Gnaiger, attended a 2-day Intellectual Property Right Webinar on patent and trade mark search.
- 2020-02-04: Our Mitochondrial Wizard Luiza Daltro Cardoso, PhD went to Japan to meet our distributor and teach him high-resolution respirometry combined with H2O2, mt-membrane potential and ATP production measurements: Distributor engagement Tokyo JP
- 2020-02-03 The O2k-Installation Qualification / Operational Qualification protocol (abbrev: IQOQ) is available now: MiPNet25.08 O2k-IQOQ protocol
- 2019-12-20: Started registration process of “NextGen-O2k” as an EU-trademark
- 2020-10-03: Erich Gnaiger travels to Fukuoka to attend J-Mit and ASMRM 2019 and meet our distributor Berthold Japan K.K.
- 2019-07-01: The first Distributor Meeting took place, see more: Oroboros Distributor Meeting
Snapshot of the J-Mit and ASMRM 2019
On-site visit in Japan
The first Distributor Meeting
The Oroboros booth at the ASMRM & J-mit 2019
